No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs183921887 |
chr1:77331726-77331727 |
Weak transcription Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs147713829 |
chr1:77331750-77331751 |
Weak transcription Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs531907937 |
chr1:77331767-77331768 |
Weak transcription Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs377760989 |
chr1:77331793-77331794 |
Weak transcription Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs116705027 |
chr1:77331851-77331852 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs540371313 |
chr1:77331874-77331875 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs141277084 |
chr1:77331912-77331913 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs532185078 |
chr1:77332001-77332002 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs200266779 |
chr1:77332011-77332012 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs186753935 |
chr1:77332039-77332040 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs568827117 |
chr1:77332056-77332057 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs529970012 |
chr1:77332091-77332092 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs377629252 |
chr1:77332105-77332106 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs567696602 |
chr1:77332131-77332132 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs534797502 |
chr1:77332275-77332276 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs142387456 |
chr1:77332357-77332358 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs553439436 |
chr1:77332383-77332384 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs112592844 |
chr1:77332394-77332395 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs191279456 |
chr1:77332395-77332396 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs9726090 |
chr1:77332398-77332399 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs557654983 |
chr1:77332419-77332420 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs575995471 |
chr1:77332427-77332428 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs562525821 |
chr1:77332438-77332439 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs543334691 |
chr1:77332499-77332500 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs367725903 |
chr1:77332595-77332596 |
Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs1522618 |
chr1:77332627-77332628 |
Weak transcription Bivalent Enhancer Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs572837149 |
chr1:77332630-77332631 |
Weak transcription Bivalent Enhancer Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs539909630 |
chr1:77332678-77332679 |
Weak transcription Bivalent Enhancer Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs114455411 |
chr1:77332763-77332764 |
Weak transcription Bivalent Enhancer Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs532140241 |
chr1:77332792-77332793 |
Weak transcription Bivalent Enhancer Active TSS Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs199624931 |
chr1:77332876-77332877 |
Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs562369776 |
chr1:77332905-77332906 |
Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs184854076 |
chr1:77332972-77332973 |
Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs548503210 |
chr1:77332992-77332993 |
Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs567506017 |
chr1:77333081-77333082 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs528486905 |
chr1:77333108-77333109 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs547085131 |
chr1:77333133-77333134 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs565864042 |
chr1:77333175-77333176 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs190680760 |
chr1:77333189-77333190 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs539172474 |
chr1:77333230-77333231 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs557569110 |
chr1:77333239-77333240 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs569520345 |
chr1:77333284-77333285 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs377131012 |
chr1:77333300-77333301 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113659117 |
chr1:77333301-77333302 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs113208751 |
chr1:77333325-77333326 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs76305167 |
chr1:77333355-77333356 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs572703660 |
chr1:77333367-77333368 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs369888538 |
chr1:77333395-77333396 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs115959772 |
chr1:77333401-77333402 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs558164719 |
chr1:77333431-77333432 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|